首页> 外国专利> TEST METHOD FOR EVALUATING THE RISK OF ANTI-THYROID DRUG-INDUCED AGRANULOCYTOSIS, AND EVALUATION KIT

TEST METHOD FOR EVALUATING THE RISK OF ANTI-THYROID DRUG-INDUCED AGRANULOCYTOSIS, AND EVALUATION KIT

机译:评估抗甲状腺药物引起的粒细胞增多症的风险的测试方法及评估套件

摘要

The present invention provides a test method and an evaluation kit for determining the risk of antithyroid drug-induced agranulocytosis. More particularly, it provides a test method for determining the risk of antithyroid drug-induced agranulocytosis, including testing susceptibility polymorphism to antithyroid drug-induced agranulocytosis, and determining the risk of antithyroid drug-induced agranulocytosis, and an evaluation kit for the risk of antithyroid drug-induced agranulocytosis, containing a polynucleotide capable of detecting susceptibility polymorphism to antithyroid drug-induced agranulocytosis.
机译:本发明提供了用于确定抗甲状腺药物诱导的粒细胞缺乏症的风险的测试方法和评估试剂盒。更具体地,它提供了确定抗甲状腺药物诱发的粒细胞缺乏症的风险的测试方法,包括测试对抗甲状腺药物诱发的粒细胞缺乏症的易感性多态性,并确定抗甲状腺药物诱发的粒细胞缺乏症的风险,以及抗甲状腺疾病的风险评估套件药物诱导的粒细胞缺乏症,其包含能够检测抗甲状腺药物诱导的粒细胞缺乏症易感性多态性的多核苷酸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号